Viewing Study NCT02083250

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:19 PM
Ignite Modification Date: 2026-03-01 @ 3:22 PM
Study NCT ID: NCT02083250
Status: COMPLETED
Last Update Posted: 2022-01-06
First Post: 2014-03-07
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Fludarabine Phosphate, Clofarabine, and Busulfan With Vorinostat in Treating Patients With Acute Leukemia in Remission or Relapse Undergoing Donor Stem Cell Transplant
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Lymphoblastic Leukemia in Remission View
None Acute Myeloid Leukemia in Remission View
None Allogeneic Hematopoietic Stem Cell Transplantation Recipient View
None Myelodysplastic Syndrome View
None Previously Treated Myelodysplastic Syndrome View
None Recurrent Acute Lymphoblastic Leukemia View
None Recurrent Acute Myeloid Leukemia View
Keywords: